{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:45:09Z","timestamp":1758707109894,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.taap.2020.115001","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:31:07Z","timestamp":1586345467000},"page":"115001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells"],"prefix":"10.1016","volume":"396","author":[{"given":"Xiaolei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9009-3786","authenticated-orcid":false,"given":"Huan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.taap.2020.115001_bb0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/neuonc\/nou234","article-title":"Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis","volume":"17","author":"Bai","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"8","key":"10.1016\/j.taap.2020.115001_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.taap.2020.115001_bb0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2017-07-794214","article-title":"Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia","volume":"131","author":"Bride","year":"2018","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.taap.2020.115001_bb0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cpt.176","article-title":"Pediatric transporter working group. Human ontogeny of drug transporters: review and recommendations of the pediatric transporter working group","volume":"98","author":"Brouwer","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.taap.2020.115001_bb0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.exppara.2006.09.004","article-title":"Angiostrongylus cantonensis: apoptosis of inflammatory cells induced by treatment with mebendazole or\/and interleukin 12 in mice","volume":"115","author":"Chuang","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.taap.2020.115001_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2119\/molmed.2017.00011","article-title":"Repurposing Mebendazole as a replacement for vincristine for the treatment of brain tumors","volume":"23","author":"De Witt","year":"2017","journal-title":"Mol. Med."},{"issue":"8","key":"10.1016\/j.taap.2020.115001_bb0035","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-07-2159","article-title":"Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells","volume":"6","author":"Doudican","year":"2008","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.taap.2020.115001_bb0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CAD.0b013e32835a43f1","article-title":"XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts","volume":"24","author":"Doudican","year":"2013","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.taap.2020.115001_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","article-title":"ABC transporters as mediators of drug resistance and contributors to cancer cell biology","volume":"26","author":"Fletcher","year":"2016","journal-title":"Drug Resist. Updat."},{"issue":"9","key":"10.1016\/j.taap.2020.115001_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091284","article-title":"Mebendazole as a candidate for drug repurposing in oncology: an extensive review of current literature","volume":"11","author":"Guerini","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"494","key":"10.1016\/j.taap.2020.115001_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6246","article-title":"Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition","volume":"11","author":"Habets","year":"2019","journal-title":"Sci Transl Med."},{"issue":"1","key":"10.1016\/j.taap.2020.115001_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yexcr.2018.05.006","article-title":"Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia","volume":"369","author":"He","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.taap.2020.115001_bb0065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nm.3955","article-title":"Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia","volume":"21","author":"Herranz","year":"2015","journal-title":"Nat. Med."},{"issue":"27","key":"10.1016\/j.taap.2020.115001_bb0070","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/s41388-019-0802-x","article-title":"The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to \u03b3-secretase inhibition","volume":"38","author":"Hounjet","year":"2019","journal-title":"Oncogene."},{"issue":"2","key":"10.1016\/j.taap.2020.115001_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10637-017-0503-7","article-title":"Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas","volume":"36","author":"Kipper","year":"2018","journal-title":"Investig. New Drugs"},{"issue":"1","key":"10.1016\/j.taap.2020.115001_bb1000","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.vetpar.2007.10.005","article-title":"Efficacy of thiabendazole, mebendazole, levamisole and ivermectin against gullet worm, Gongylonema pulchrum: in vitro and in vivo studies","volume":"151","author":"Kudo","year":"2008","journal-title":"Vet. Parasitol."},{"issue":"1","key":"10.1016\/j.taap.2020.115001_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-14-0755-T","article-title":"Repurposing the antihelmintic mebendazole as a hedgehog inhibitor","volume":"14","author":"Larsen","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.taap.2020.115001_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0609.2006.00686.x","article-title":"Establishment of a nude mice model of human monocytic leukemia with CNS and multiorgan extramedullary infiltration","volume":"77","author":"Li","year":"2006","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.taap.2020.115001_bb0090","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1172\/JCI75821","article-title":"Inhibition of IRAK1\/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies","volume":"125","author":"Li","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.taap.2020.115001_bb0095","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/blood.V82.11.3445.3445","article-title":"Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia\/acute lymphoblastic leukemia","volume":"82","author":"Miwa","year":"1993","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.taap.2020.115001_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24112152","article-title":"Benzimidazoles downregulate Mdm2 and MdmX and activate p53 in MdmX overexpressing tumor cells","volume":"24","author":"Mrkvov\u00e1","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.taap.2020.115001_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2015.07.013","article-title":"Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells","volume":"367","author":"Munoz","year":"2015","journal-title":"Cancer Lett."},{"issue":"48","key":"10.1016\/j.taap.2020.115001_bb0110","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.taap.2020.115001_bb0115","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.tiv.2015.08.007","article-title":"The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model","volume":"29","author":"Pinto","year":"2015","journal-title":"Toxicol. in Vitro"},{"issue":"9","key":"10.1016\/j.taap.2020.115001_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12032-016-0809-x","article-title":"Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine","volume":"33","author":"Rose-James","year":"2016","journal-title":"Med. Oncol."},{"issue":"9","key":"10.1016\/j.taap.2020.115001_bb0125","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","article-title":"The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia","volume":"129","author":"Sanchez-Martin","year":"2017","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.taap.2020.115001_bb0130","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1073\/pnas.1611831114","article-title":"Synergistic antileukemic therapies in NOTCH1-induced T-ALL","volume":"114","author":"Sanchez-Martin","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.taap.2020.115001_bb0135","first-page":"1201","article-title":"The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells","volume":"1","author":"Sasaki","year":"2002","journal-title":"Mol. Cancer Ther."},{"issue":"32","key":"10.1016\/j.taap.2020.115001_bb0140","doi-asserted-by":"crossref","first-page":"26648","DOI":"10.1021\/acsami.7b05292","article-title":"Co-delivery of Trichosanthin and Albendazole by Nano-self-assembly for overcoming tumor multidrug-resistance and metastasis","volume":"9","author":"Tang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.taap.2020.115001_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.smim.2011.08.007","article-title":"On becoming a T cell, a convergence of factors kick it up a Notch along the way","volume":"23","author":"Thompson","year":"2011","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.taap.2020.115001_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.blre.2017.08.006","article-title":"T cell acute lymphoblastic leukemia (T-ALL): new insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies","volume":"32","author":"Vadillo","year":"2018","journal-title":"Blood Rev."},{"issue":"5694","key":"10.1016\/j.taap.2020.115001_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science."},{"issue":"15","key":"10.1016\/j.taap.2020.115001_bb0160","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"C-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.taap.2020.115001_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/toxsci\/kfx075","article-title":"Efflux transporters regulate Arsenite-induced genotoxicity in double negative and double positive T cells","volume":"158","author":"Xu","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2020.115001_bb0170","doi-asserted-by":"crossref","first-page":"19095","DOI":"10.1038\/s41598-019-55666-x","article-title":"Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma","volume":"9","author":"Younis","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2020.115001_bb0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2017.11.009","article-title":"Inhibition of Notch1\/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells","volume":"818","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2020.115001_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijrobp.2018.08.046","article-title":"Mebendazole potentiates radiation therapy in triple-negative breast Cancer","volume":"103","author":"Zhang","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.taap.2020.115001_bb0185","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1021\/acs.jmedchem.7b01792","article-title":"N-substituted prodrugs of Mebendazole provide improved Aqueous solubility and Oral bioavailability in mice and dogs","volume":"61","author":"Zimmermann","year":"2018","journal-title":"J. Med. Chem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20301253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20301253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:50:00Z","timestamp":1758574200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X20301253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"alternative-id":["S0041008X20301253"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2020.115001","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2020.115001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115001"}}